# EDGAR Filing Document

**Accession Number:** 0001874169
**File Stem:** 0001104659-26-075743
**Filing Date:** 2026-6
**Character Count:** 8276
**Document Hash:** 73eabc23d5484eebbbdb88bb42ead7c0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-075743.hdr.sgml**: 20260618

**ACCESSION NUMBER**: 0001104659-26-075743

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260616

**FILED AS OF DATE**: 20260618

**DATE AS OF CHANGE**: 20260618

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Browers Blaine
- **CENTRAL INDEX KEY:** 0001874169

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40698
- **FILM NUMBER:** 261102827

**MAIL ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PARKWAY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cadre Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001860543
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 383873146
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PKWY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218
- **BUSINESS PHONE:** (904) 741-5400

**MAIL ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PKWY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Browers Blaine<br><sub>(Last) (First) (Middle)</sub><br>C/O CADRE HOLDINGS, INC.<br>13386 INTERNATIONAL PKWY<br><sub>(Street)</sub><br>JACKSONVILLE, FL 32218<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-16 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CHIEF FINANCIAL OFFICER_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Cadre Holdings, Inc. [ CDRE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2026-06-16 |  | A |  | 48500 |  | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 48500 | $0 | 48500 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2026-06-16 |  | A |  | 69500 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 69500 | $0 | 69500 | D |  |
| Stock Option (right to purchase) | $28.75 | 2026-06-16 |  | A |  | 92500 |  | <sup>(3)</sup> | 2033-06-16 | Common Stock | 92500 | $0 | 92500 | D |  |
| Stock Option (right to purchase) | $28.75 | 2026-06-16 |  | A |  | 115000 |  | <sup>(4)</sup> | 2033-06-16 | Common Stock | 115000 | $0 | 115000 | D |  |

---

### Footnotes:

(1) Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.

(2) Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.

(3) The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 92,500 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.

(4) The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 115,000 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.

**Signature:** /s/ Blaine Browers  
**Date:** 2026-06-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**